Allelic Variants
|
|
There are no related allelic variants
|
|
| Number of involved diseases in the family |
69 |
| Number of CSF1R related diseases |
2 |
All kinase in this family
CSF1R
Allelic
Variants |
Disease Description |
Involved kinases
(This family) |
Inhibitor of
Involved Kinases |
Search
Disease |
| Melanoma | EGFR, FGFR1, IGF1R, MET,
PDGFRA | 18 | Link | | Prostate cancer | EGFR, ERBB2, FGFR1, IGF1R,
PDGFRA | 15 | Link | | n/a | Epithelial cell signaling in Helicobacter pylori infection | EGFR, LYN, MET, SRC | 18 | Link | | Gastric cancer | EGFR, ERBB2, MET | 4 | Link | | n/a | Choriocarcinoma | CSF1R, EGFR, ERBB2 | 31 | Link | | SCID | JAK3, LCK | 14 | Link | | n/a | Epstein-Barr virus infection | JAK3, LYN | 10 | Link | | n/a | Immunodeficiencies | JAK3, LCK | 14 | Link | | Adenocarcinoma of lung | EGFR, ERBB2 | 1 | Link | | Leukemia | JAK2, KIT | 18 | Link | | n/a | Measles | JAK2, JAK3 | 9 | Link | | n/a | Tuberculosis | JAK2, SRC | 21 | Link | | Gastrointestinal stromal tumor | KIT, PDGFRA | 12 | Link | | n/a | Glioma | EGFR, PDGFRA | 2 | Link | | Lung cancer | ALK, EGFR | 2 | Link | | n/a | Cholangiocarcinoma | ERBB2, MET | 4 | Link | | n/a | Bladder cancer | EGFR, ERBB2 | 1 | Link | | n/a | Cervical cancer | EGFR, ERBB2 | 1 | Link | | Neuroblastoma | ALK, NTRK1 | 4 | Link | | Endometrial Cancer | ERBB2 | 1 | Link | | Trigonocephaly | FGFR1 | 3 | Link | | Jackson-Weiss syndrome | FGFR1 | 3 | Link | | Osteoglophonic dysplasia | FGFR1 | 3 | Link | | Ovarian cancer | ERBB2 | 1 | Link | | Breast cancer | ERBB2 | 1 | Link | | Glioblastoma | ERBB2 | 1 | Link | | Hypogonadotropic hypogonadism | FGFR1 | 3 | Link | | n/a | Hepatitis C | EGFR | 1 | Link | | n/a | Pancreatic cancer | ERBB2 | 1 | Link | | Agammaglobulinemia | BTK | 1 | Link | | n/a | Pituitary Dwarfism | BTK | 1 | Link | | n/a | Agammaglobulinemias | BTK | 1 | Link | | n/a | Agammaglobulinemia and isolated hormone deficiency | BTK | 1 | Link | | n/a | Leukoencephalopathy, diffuse hereditary, with spheroids | CSF1R | 30 | Link | | Kallmann syndrome | FGFR1 | 3 | Link | | n/a | Laryngeal cancer | EGFR | 1 | Link | | n/a | Esophageal cancer | EGFR | 1 | Link | | n/a | Oral cancer | EGFR | 1 | Link | | Insulin-like growth factor I | IGF1R | 10 | Link | | Pfeiffer syndrome | FGFR1 | 3 | Link | | n/a | Malaria | MET | 3 | Link | | Renal cell carcinoma | MET | 3 | Link | | Mastocytosis with associated hematologic disorder | KIT | 11 | Link | | n/a | Germ cell tumors | KIT | 11 | Link | | Mast cell leukemia | KIT | 11 | Link | | n/a | Autism suseptibility | MET | 3 | Link | | Hepatocellular carcinoma | MET | 3 | Link | | n/a | Shigellosis | SRC | 14 | Link | | Colon cancer | SRC | 14 | Link | | n/a | Hypereosinophilic syndrome | PDGFRA | 1 | Link | | n/a | Medullary thyroid carcinoma | NTRK1 | 3 | Link | | n/a | Thyroid cancer | NTRK1 | 3 | Link | | n/a | Insensitivity to pain | NTRK1 | 3 | Link | | Piebaldism | KIT | 11 | Link | | Thrombocythemia | JAK2 | 8 | Link | | Diabetes mellitus | INSR | 7 | Link | | Hyperinsulinemic hypoglycemia | INSR | 7 | Link | | Rabson-Mendenhall syndrome | INSR | 7 | Link | | n/a | Leprechaunism | INSR | 7 | Link | | n/a | Malignant pleural mesothelioma | IGF1R | 10 | Link | | n/a | Synovial sarcoma | IGF1R | 10 | Link | | Polycythemia vera | JAK2 | 8 | Link | | n/a | Leishmaniasis | JAK2 | 8 | Link | | Myelofibrosis | JAK2 | 8 | Link | | n/a | Myeloproliferative disorder | JAK2 | 8 | Link | | n/a | Budd-Chiari syndrome | JAK2 | 8 | Link | | n/a | Herpes simplex infection | JAK2 | 8 | Link | | n/a | Toxoplasmosis | JAK2 | 8 | Link | | n/a | Influenza A | JAK2 | 8 | Link |
|